New nasal cannula could ease breathing for COPD patients
NCT ID NCT05829083
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study compares a new asymmetric nasal cannula (DUET) to a standard one in 50 people with mild-to-moderate COPD flare-ups and high carbon dioxide levels. Each participant will try both devices for 3 hours to see which lowers CO2 better, reduces breathing effort, and feels more comfortable. The goal is to find a simpler way to help patients breathe easier and avoid more intensive treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Asymmetric nasal cannula (DUET device)
What this could lead to
If it works, this could offer a more effective way to help COPD patients breathe easier during flare-ups, potentially reducing the need for more intensive breathing support.
What could go wrong
This is a small, early crossover study with only 50 participants. The new cannula may not be more effective than the standard one, and some patients may find it uncomfortable or difficult to tolerate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sotiria General Hospital
RECRUITINGAthens, 11527, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Hospital of Larissa
RECRUITINGLarissa, 41110, Greece
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact